Comments

Glaukos Stock Price, Quotes and Forecasts

Q: What sector and industry does Glaukos (GKOS) operate in?

Glaukos is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.

GKOSNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$107.61

0.000.00%

Pre-Market: 4:00 PM EDT

Glaukos (GKOS) Forecast

News Earnings Glaukos (GKOS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Glaukos Stock Price, Quotes and Forecasts | NYSE:GKOS | Benzinga

Explore Glaukos stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GKOS.

Open	-
Close	-
Volume / Avg.	43.00 / 827.36K
Day Range	- - -
52 Wk Range	87.31 - 163.71
Market Cap	$6.09B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	48
Short Interest	9.87%
Days to Cover	2.51

Recent News

FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery

Glaukos' Epioxa NDA for keratoconus is under FDA review, with a decision expected by October 2025. Phase 3 trials support its non-invasive treatment potential.

Vandana Singh

Consumer Sentiment Drops 10%, UnitedHealth Under Investigation: What's Driving Markets Friday?

All three major U.S. stock indices are down Friday as traders reacted to several sets of fresh data that raised concerns about the economic outlook.

Erica Kollmann

Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition

Glaukos reported Q4 sales of $105.5 million, surpassing estimates, while EPS missed. Analysts see strong growth potential as the company expands its business model.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	43.00 / 827.36K
Day Range	- - -
52 Wk Range	87.31 - 163.71
Market Cap	$6.09B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	48
Short Interest	9.87%
Days to Cover	2.51

About Glaukos Corporation

Sector

Health Care

Industry

Health Care Equipment & Supplies

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing no...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Glaukos (GKOS) stock?

You can purchase shares of Glaukos (NYSE:GKOS) through any online brokerage.

View our list of the best stock brokerages

Who are Glaukos (GKOS) competitors?

Other companies in Glaukos’s space includes: Steris (NYSE:STE), Masimo (NASDAQ:MASI), Koninklijke Philips (NYSE:PHG), Smith & Nephew (NYSE:SNN) and Abbott Laboratories (NYSE:ABT).

What is the forecast, or price target, for Glaukos (GKOS) stock?

Glaukos has a consensus price target of $155.07.

What is the current price for Glaukos (GKOS)?

The stock price for Glaukos (NYSE: GKOS) is $107.61 last updated March 24, 2025 at 4:00 PM EDT.

Does Glaukos (GKOS) pay a dividend?

There are no upcoming dividends for Glaukos.

When is Glaukos (NYSE:GKOS) reporting earnings?

Glaukos’s Q1 earnings are confirmed for Wednesday, April 30, 2025.

Is Glaukos (GKOS) going to split?

There is no upcoming split for Glaukos.

What sector and industry does Glaukos (GKOS) operate in?

Glaukos is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.